TrialBlood2014

A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.

Edward A Stadtmauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.